50 related articles for article (PubMed ID: 21163258)
1. An adjacent arginine, and the phosphorylated tyrosine in the c-Met receptor target sequence, dictates the orientation of c-Cbl binding.
Sun Q; Ng C; Guy GR; Sivaraman J
FEBS Lett; 2011 Jan; 585(2):281-5. PubMed ID: 21163258
[TBL] [Abstract][Full Text] [Related]
2. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates.
Ng C; Jackson RA; Buschdorf JP; Sun Q; Guy GR; Sivaraman J
EMBO J; 2008 Mar; 27(5):804-16. PubMed ID: 18273061
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
Hu J; Hubbard SR
J Biol Chem; 2005 May; 280(19):18943-9. PubMed ID: 15737992
[TBL] [Abstract][Full Text] [Related]
5. Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.
Sun Q; Jackson RA; Ng C; Guy GR; Sivaraman J
PLoS One; 2010 Sep; 5(9):e12819. PubMed ID: 20877636
[TBL] [Abstract][Full Text] [Related]
6. Structural flexibility regulates phosphopeptide-binding activity of the tyrosine kinase binding domain of Cbl-c.
Takeshita K; Tezuka T; Isozaki Y; Yamashita E; Suzuki M; Kim M; Yamanashi Y; Yamamoto T; Nakagawa A
J Biochem; 2012 Nov; 152(5):487-95. PubMed ID: 22888118
[TBL] [Abstract][Full Text] [Related]
7. Structure of the amino-terminal domain of Cbl complexed to its binding site on ZAP-70 kinase.
Meng W; Sawasdikosol S; Burakoff SJ; Eck MJ
Nature; 1999 Mar; 398(6722):84-90. PubMed ID: 10078535
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of signaling through the B cell antigen receptor by the protooncogene product, c-Cbl, requires Syk tyrosine 317 and the c-Cbl phosphotyrosine-binding domain.
Yankee TM; Keshvara LM; Sawasdikosol S; Harrison ML; Geahlen RL
J Immunol; 1999 Dec; 163(11):5827-35. PubMed ID: 10570266
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the MET receptor on juxtamembrane tyrosine residue 1001 inhibits its caspase-dependent cleavage.
Deheuninck J; Goormachtigh G; Foveau B; Ji Z; Leroy C; Ancot F; Villeret V; Tulasne D; Fafeur V
Cell Signal; 2009 Sep; 21(9):1455-63. PubMed ID: 19450681
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein.
Peschard P; Fournier TM; Lamorte L; Naujokas MA; Band H; Langdon WY; Park M
Mol Cell; 2001 Nov; 8(5):995-1004. PubMed ID: 11741535
[TBL] [Abstract][Full Text] [Related]
11. Structural analysis of the TKB domain of ubiquitin ligase Cbl-b complexed with its small inhibitory peptide, Cblin.
Ohno A; Ochi A; Maita N; Ueji T; Bando A; Nakao R; Hirasaka K; Abe T; Teshima-Kondo S; Nemoto H; Okumura Y; Higashibata A; Yano S; Tochio H; Nikawa T
Arch Biochem Biophys; 2016 Mar; 594():1-7. PubMed ID: 26874193
[TBL] [Abstract][Full Text] [Related]
12. C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus.
Wilhelmsen K; Burkhalter S; van der Geer P
Oncogene; 2002 Feb; 21(7):1079-89. PubMed ID: 11850825
[TBL] [Abstract][Full Text] [Related]
13. Identification and functional characterization of an Src homology domain 3 domain-binding site on Cbl.
Sanjay A; Miyazaki T; Itzstein C; Purev E; Horne WC; Baron R
FEBS J; 2006 Dec; 273(23):5442-56. PubMed ID: 17094785
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a.
Schiering N; Knapp S; Marconi M; Flocco MM; Cui J; Perego R; Rusconi L; Cristiani C
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12654-9. PubMed ID: 14559966
[TBL] [Abstract][Full Text] [Related]
15. Sprouty proteins: modified modulators, matchmakers or missing links?
Guy GR; Jackson RA; Yusoff P; Chow SY
J Endocrinol; 2009 Nov; 203(2):191-202. PubMed ID: 19423641
[TBL] [Abstract][Full Text] [Related]
16. Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.
Masson K; Heiss E; Band H; Rönnstrand L
Biochem J; 2006 Oct; 399(1):59-67. PubMed ID: 16780420
[TBL] [Abstract][Full Text] [Related]
17. D-Cbl, the Drosophila homologue of the c-Cbl proto-oncogene, interacts with the Drosophila EGF receptor in vivo, despite lacking C-terminal adaptor binding sites.
Hime GR; Dhungat MP; Ng A; Bowtell DD
Oncogene; 1997 Jun; 14(22):2709-19. PubMed ID: 9178769
[TBL] [Abstract][Full Text] [Related]
18. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
Eck MJ; Shoelson SE; Harrison SC
Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation.
Sawasdikosol S; Chang JH; Pratt JC; Wolf G; Shoelson SE; Burakoff SJ
J Immunol; 1996 Jul; 157(1):110-6. PubMed ID: 8683103
[TBL] [Abstract][Full Text] [Related]
20. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
